1. Home
  2. CACI vs BIO Comparison

CACI vs BIO Comparison

Compare CACI & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CACI
  • BIO
  • Stock Information
  • Founded
  • CACI 1962
  • BIO 1952
  • Country
  • CACI United States
  • BIO United States
  • Employees
  • CACI N/A
  • BIO N/A
  • Industry
  • CACI EDP Services
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CACI Technology
  • BIO Industrials
  • Exchange
  • CACI Nasdaq
  • BIO Nasdaq
  • Market Cap
  • CACI 11.4B
  • BIO 9.5B
  • IPO Year
  • CACI 1979
  • BIO N/A
  • Fundamental
  • Price
  • CACI $529.93
  • BIO $343.99
  • Analyst Decision
  • CACI Buy
  • BIO Strong Buy
  • Analyst Count
  • CACI 11
  • BIO 4
  • Target Price
  • CACI $485.60
  • BIO $381.50
  • AVG Volume (30 Days)
  • CACI 103.9K
  • BIO 468.5K
  • Earning Date
  • CACI 10-23-2024
  • BIO 10-30-2024
  • Dividend Yield
  • CACI N/A
  • BIO N/A
  • EPS Growth
  • CACI 13.21
  • BIO N/A
  • EPS
  • CACI 18.60
  • BIO N/A
  • Revenue
  • CACI $7,659,832,000.00
  • BIO $2,562,604,000.00
  • Revenue This Year
  • CACI $7.05
  • BIO N/A
  • Revenue Next Year
  • CACI $4.94
  • BIO $4.49
  • P/E Ratio
  • CACI $28.48
  • BIO N/A
  • Revenue Growth
  • CACI 14.28
  • BIO N/A
  • 52 Week Low
  • CACI $302.21
  • BIO $261.59
  • 52 Week High
  • CACI $533.03
  • BIO $364.24
  • Technical
  • Relative Strength Index (RSI)
  • CACI 75.61
  • BIO 56.50
  • Support Level
  • CACI $525.21
  • BIO $329.08
  • Resistance Level
  • CACI $532.74
  • BIO $346.09
  • Average True Range (ATR)
  • CACI 6.21
  • BIO 8.23
  • MACD
  • CACI 1.11
  • BIO -0.23
  • Stochastic Oscillator
  • CACI 91.43
  • BIO 70.12

About CACI CACI International Inc.

CACI International Inc is an information solutions and services provider, offering information solutions and services to its customers. The company's primary customers are agencies and departments of the U.S. government, which account for the vast majority of the firm's revenue. It provides information solutions and services supporting national security missions and government modernization for intelligence, defense, and federal civilian customers. Some of the services provided by the company are functional software development, data, and business analysis, IT operations support, naval architecture, and life cycle support intelligence among others. The company's operating segments are; Domestic operations and International operations. It derives key revenue from the Domestic segment.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: